title: [Oxaliplatin: combinations with thymidylate synthetase inhibitors: two consecutive phase II studies].
authors: UO di Oncologia Medica, Dipartimento di Oncologia e Ematologia, Policlinico Sant'Orsola-Malpighi, Bologna.
authors: A
authors: A
authors: Martoni
authors: E
authors: E
authors: Mini
authors: C
authors: C
authors: Pinto
authors: A
authors: A
authors: Gentile
authors: T
authors: T
authors: Mazzei
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D017322:Clinical Trials, Phase II as Topic; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D004334:Drug Administration Schedule; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D009944:Organoplatinum Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D000077150:Oxaliplatin; D011799:Quinazolines / Q000008:administration & dosage; D013876:Thiophenes / Q000008:administration & dosage; D013940:Thymidylate Synthase / Q000037:antagonists & inhibitors*; D016896:Treatment Outcome
chemical_list: D000964:Antimetabolites, Antineoplastic; D004791:Enzyme Inhibitors; D009944:Organoplatinum Compounds; D011799:Quinazolines; D013876:Thiophenes; D000077150:Oxaliplatin; D013940:Thymidylate Synthase; C068874:raltitrexed; D005472:Fluorouracil